Position in SNDX
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$2,715,906
-$171,061 QoQ
Shares Held
124,241
+0.5% QoQ
Ownership
0.139%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#92
of 242 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 98%
None 2%
Common Shares in SNDX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026WELLINGTON MANAGEMENT GROUP LLP holds $14,994,233,945 across 206 Biotechnology names. SNDX ranks #103 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
3,247,658 | $1,613,209,155 | |
| 2 | ARGX |
Argenx SE
|
930,548 | $863,334,513 | |
| 3 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,270,087 | $791,950,042 | |
| 4 | RVMD |
Revolution Medicines, Inc.
|
3,843,415 | $719,794,757 | |
| 5 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
2,110,407 | $635,295,816 | |
| 6 | IONS |
Ionis Pharmaceuticals Inc
|
7,651,415 | $606,680,693 | |
| 7 | CYTK |
Cytokinetics Inc
|
6,931,770 | $590,517,483 | |
| 8 | MDGL |
Madrigal Pharmaceuticals, Inc.
|
825,714 | $443,367,129 |
All Filings in SNDX
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,715,906 | 124,241 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $2,886,967 | 123,586 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $748,584 | 35,630 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $588,105 | 38,226 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $319,204 | 34,085 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $441,791 | 35,962 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $55,979,491 | 4,234,455 | Shares | Defined | 2025-02-12 | |
| 2024-09-30 | $95,980,035 | 4,985,976 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $150,669,749 | 7,339,004 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $176,991,457 | 7,436,616 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $163,916,621 | 7,585,221 | Shares | Defined | 2024-02-12 | |
| 2023-09-30 | $110,968,312 | 7,642,446 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $155,806,768 | 7,444,184 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $147,918,860 | 7,003,734 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $203,178,595 | 7,983,442 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $105,430,180 | 4,387,440 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $61,700,099 | 3,206,866 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $31,873,702 | 1,833,930 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $34,996,986 | 1,598,766 | Shares | Defined | 2022-02-11 | |
| 2021-09-30 | $32,044,773 | 1,676,859 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $28,088,934 | 1,635,931 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $66,520,819 | 2,974,992 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $58,167,451 | 2,615,443 | Shares | Defined | 2021-02-12 | |
| 2020-09-30 | $49,159,180 | 3,330,568 | Shares | Defined | 2020-11-16 | |
| 2020-06-30 | $55,675,003 | 3,756,748 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $32,905,926 | 2,999,629 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||